A5076036321- Cardiac Valve Diseases and Treatments
- Cardiac Structural Anomalies and Repair
- Cardiovascular Function and Risk Factors
- Long-Term Effects of COVID-19
- Pulmonary Hypertension Research and Treatments
- Infective Endocarditis Diagnosis and Management
- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Congenital heart defects research
- Cardiac Arrhythmias and Treatments
- Zebrafish Biomedical Research Applications
- Mechanical Circulatory Support Devices
- Cardiomyopathy and Myosin Studies
- Cardiovascular and Diving-Related Complications
- Advanced Fluorescence Microscopy Techniques
- Acute Kidney Injury Research
- Aortic Disease and Treatment Approaches
- Single-cell and spatial transcriptomics
- Parathyroid Disorders and Treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Cardiac pacing and defibrillation studies
Columbia University
2020-2024
Columbia University Irving Medical Center
2020-2023
NewYork–Presbyterian Hospital
2021-2023
New York Hospital Queens
2021
Massachusetts General Hospital
2019
Harvard University
2019
Harvard Stem Cell Institute
2019
To characterize patients with coronavirus disease 2019 (covid-19) in a large New York City medical center and describe their clinical course across the emergency department, hospital wards, intensive care units.Retrospective manual record review.NewYork-Presbyterian/Columbia University Irving Medical Center, quaternary academic City.The first 1000 consecutive positive result on reverse transcriptase polymerase chain reaction assay for severe acute respiratory syndrome 2 (SARS-CoV-2) who...
Abstract Objective To characterize patients with coronavirus disease 2019 (COVID-19) in a large New York City (NYC) medical center and describe their clinical course across the emergency department (ED), inpatient wards, intensive care units (ICUs). Design Retrospective manual record review. Setting NewYork-Presbyterian/Columbia University Irving Medical Center (NYP/CUIMC), quaternary academic NYC. Participants The first 1000 consecutive laboratory-confirmed COVID-19. Methods We identified...
The objective of this study was to evaluate the incidence and risk factors associated with cardiogenic shock (CS) following surgery versus transcatheter tricuspid valve intervention (TTVI) for regurgitation (TR).Surgical therapy TR is high rates CS. Postprocedural has not been studied TTVI.We performed a single-center retrospective analysis isolated (TV) or TTVI TR. primary outcome postprocedural class D E CS according Society Cardiovascular Angiography Interventions (SCAI) classification...
Abstract Aims Characterize the impact of residual tricuspid regurgitation (TR) on right ventricle (RV) remodeling and clinical outcomes after transcatheter valve intervention. Methods We performed a single‐center retrospective analysis repair (TTVr) or replacement (TTVR) patients. The primary were longitudinal annular plane systolic excursion (TAPSE), fractional area change (FAC), pulmonary artery pressure (PASP), RV dimensions (RVd). used multivariable linear mixed models to evaluate...
Transcatheter tricuspid valve-in-valve (TViV) and valve in-ring (TViR) implantation have become a viable therapy for failed bioprosthesis. Here we report short (thirty days) long (one-year) term clinical outcomes of ten patients who underwent TViV at our institution.The electronic databases New York Presbyterian Columbia Medical Center were retrospectively reviewed cases transcatheter replacement (TViV or TViR). Between 2012 2019, data from collected. The primary safety outcome was...
Central MessageWe report the first combined transcatheter LV pseudoaneurysm plug and mitral valve-in-valve show its efficacy in growing cohort of patients with structural valvular degeneration pseudoaneurysm.See Commentaries on pages 130 131. We pseudoaneurysm. See Transcatheter has emerged as a viable alternative to repeat surgical valve replacement for high-risk degeneration.1Rodès-Cabau J. Kalavrouziotis D. replacement: new gold standard treating bioprosthesis failure?.JACC Cardiovasc...
Background: ATTR-CM has an age dependent prevalence and is a disorder that almost exclusively affects older adults. Objective evaluations of function are critical to assessing managing in The short physical performance battery (SPPB) valid measure functional capacity predicts morbidity mortality adults but its utility remains unknown. Aims/hypothesis: To establish SPPB as useful marker disease severity predictor outcomes ATTR-CM. We hypothesized scores would correlate with validated markers...
Moses, Andrew A.; Assal, Amer; Asadourian, Paul; Bautista, Anson G.; Boyd, Rebekah; Dershowitz, Lyle; Gans, Aaron; Ha, Catherine; Mcmullen, Hannah L.; Nattakom, Mary; Perez, Olivia D.; Stonesifer, Connor; Stringer, William S.; Xiong, Yuqing; Shirazian, Shayan Author Information
Introduction: Advanced tricuspid regurgitation (TR) is associated with adverse cardiovascular outcomes. Herein, we report demographics of patients presenting to a tertiary valve center and characterize measures TR severity right ventricular (RV) function. Methods: We conducted single retrospective analysis referred specialty clinic from January 2016 September 2020 primary or secondary diagnosis regurgitation. Baseline clinical, echocardiographic, hemodynamic variables were evaluated....